I didn't know about trio. Is there someone who has experience in both AndroidAPS and trio? My son would like to switch to Apple ecosystem but aaps keeps him in android.
You should not use this if you have Type-1 diabetes. It's (supposedly) not cleared to the same FDA standards, and if you tell the app you're diabetic, it locks you out from using this. I'm under the impression the Stelo (OTC version) is the same as the G7 (prescription version) with a different logo and box. I think the only practical difference is that this version has a longer lifespan (15 vs <10 days), and that it's not configured to actually alarm when it detects something dangerous. I'm not sure if any science showed the last 5 days have reduced accuracy, but I wouldn't risk my health on it if there were alternatives available.
If you have T1d, you've been able to get the prescription-variant of this product for years with insurance, so there really is no reason to get this unless you're un-insured.
The lack of a hypo alarm is the reason the Stelo is not past FDA, yet.
Luckily, there's xDrip4iOS and xDrip++, not to mention Suggah and others, who will happily do the alarming part for you. Not to mention, that to many of us T1D, the CGM is just a secondary data point for our loop, which has a CGM already built in.
I beliebe xdrip is not (yet) steel compatible. Also interesting to see if this thing really sends data only every 15mins or is it done in the app. 15min is way too much for looping.
Surely you’re not a US resident, because “covered by insurance” is definitely not a good enough reason on its own to not consider this here. 30 days of CGM device coverage from our insurance costs more than this.
That said, one actually legitimate reason a T1D may be better off with their prescribed device is if Dexcom doesn’t readily replace the OTC versions the way they do for prescriptions.
This happens way more often than I imagine most who are unfamiliar would think. Anecdotal from an internet stranger, but just last night, we had a third G7 in a row fail well before the 10 day timeline. And speaking of insurance..they wouldn’t cover the early refill we tried to get a week ago when we hadn’t yet received replacements from Dexcom.
Each insurance is different, of course, and it depends on the patient. It also varies if you’re type 1 or 2, and if you’re prescribed insulin. I’m not either, so I don’t know for sure. The American healthcare system (which I am part of) is pretty opaque.
That said, I’ve heard people quote an insurance price of about $100/mo for a g7 (which is the same as this), and Medicare should cover it outright. I’ve seen companies sells the G7 for ~$200/mo if you don’t have insurance, but without a prescription I’ve never actually gone and bought one so I don’t know if I’m missing something.
> If you have T1d, you've been able to get the prescription-variant of this product for years with insurance, so there really is no reason to get this unless you're un-insured.
is dishonest at face value.
The OOP cost can wildly vary per insurer. As important is whether or not the insurance company covers it when you need it.
Typically insurance only covers 30 days at a time. That means on day 29, insurance will refuse to cover the cost at the pharmacy.
Real world schedules, flukey tech and devices, fluctuating pharmacy inventory, and occasionally needing an endo to confirm that you still aren’t the first person in human history to reverse Type 1 diabetes, etc. make “this was covered by prescription insurance” a flimsy-at-best argument against T1Ds considering this.
Well in Finland we seem to produce promising "early-stage" companies which are then eagerly sold to bigger players. Vs in Sweden there is will (and capital) to keep growing these.
> It’s interesting to see how Nokia succumbed to the bad strategy that had almost killed Apple in ‘97.
Well, here is one take;
> Nokia’s ultimate fall can be put down to internal politics. In short, Nokia people weakened Nokia people and thus made the company increasingly vulnerable to competitive forces. When fear permeated all levels, the lower rungs of the organisation turned inward to protect resources, themselves and their units, giving little away, fearing harm to their personal careers. Top managers failed to motivate the middle managers with their heavy-handed approaches and they were in the dark with what was really going on. [1]
Well, the Linux based Maemo OS I had in 2005 0r 2006 on my Nokia 770 was already promising, although the hardware was quite slow and limited, but it was an open system one would have root access to out of the box. Then it evolved into Meego, which was even better and was then employed by the Nokia N9. Nokia already had the OS to transition to from the old Symbian, but after the Microsoft deal, they scrapped it to adopt Windows Mobile, and the rest is history.
Maemo and MeeGo and other Nokia OSs were more coherent than Microsoft's phone OSs at the time, and Symbian would have had a long life on cheap devices. Smartphones were expensive back then.
In the UK there was a brief period from 2009-2011 where everyone seemed to replace their Nokia with a Blackberry before iPhones became common (BBM was a big thing)
I can remember one Christmas, perhaps 2010, where my Facebook feed was just folks posting their BBM pins. Ah, what a throwback.
In retrospect, a better idea than giving out your phone number as WhatsApp requires. And indeed, people were more willing to share BBM pins than phone numbers.
In the UK + US they did.. In the EU, Nokia was king, but there were many other brands and OSes (windows mobile). Japan always had a different market though.
Nokia was still a large player, but was loosing ground.
Android at the time (the betas) resembled blackberry, and didn't feature any touch capabilities.
Right after the iPhone was released, Android changed its UI.
Nokia was globally dominant until 2010, when Android started rapidly eating its market share.
Japan and the US were both countries with their own weird mobile phone markets. The US market was not as relevant in the 2000s as it should have been. Mobile phone adoption was lower than in Europe and the plans were ridiculously expensive, mostly because of the dominant business model. The plan was the primary product and the phone was a generic device locked to the plan, making the market uninteresting for phone manufacturers.
I don't know if I've ever seen a Blackberry phone knowing that it's a Blackberry phone. Blackberries always sounded like the Atari ST: a device you constantly heard about but never saw in the real world. And when I saw some statistics much later, I was surprised how popular it had been in the US.
Not really. It was the Nokia board that wanted to be taken over. They were looking for a mark, and Microsoft walked right into it. Nokia dropped the phone division on Microsoft and Microsoft then had to write it down.
In Finland the tender was between Cerner and Epic. Because our largest hospital district wanted to buy American eletronic medical record system. I guess the biggest influencer was Kaiser Permanante (=they are world class and are using Epic, so it has to be best system in the world)
